[Minimally-invasive surgery in cancer children]

Marc-David Leclair1, Sabine Sarnacki, François Varlet

  • 1Service de chirurgie infantile, Hôpital Mère-Enfant, CHU, 44093 Nantes Cedex, France. marcdavid.leclair@chu-nantes.fr

Bulletin Du Cancer
|December 25, 2007
PubMed

Insights

Minimally-invasive surgery (MIS) offers diagnostic and treatment benefits for pediatric solid tumors. MIS techniques reduce patient trauma and discomfort, leading to shorter hospital stays.

Area of Science:

  • Pediatric oncology
  • Surgical oncology
  • Minimally-invasive surgery

Context:

  • Malignant solid tumors in children present unique surgical challenges.
  • Minimally-invasive surgery (MIS) encompasses techniques like laparoscopy, retroperitoneoscopy, and thoracoscopy.
  • These methods are employed for both diagnostic biopsies and therapeutic resections.

Purpose:

  • To evaluate the application and benefits of minimally-invasive surgery in pediatric oncology.
  • To highlight the advantages of MIS over traditional open surgery for pediatric solid tumors.

Summary:

  • Minimally-invasive surgery (MIS) is utilized for diagnosing and treating pediatric malignant solid tumors.
  • Techniques include laparoscopy, retroperitoneoscopy, and thoracoscopy for biopsies and resections.
  • Key indications involve neuroblastoma, lymphoma residual masses, and retroperitoneal tumors.

Impact:

  • MIS reduces parietal trauma, leading to cosmetic benefits and fewer bowel adhesions.
  • Patients experience less postoperative discomfort, including reduced pain and shorter hospital stays.
  • MIS facilitates effective treatment for various pediatric cancers, improving patient outcomes.

Related Concept Videos